Short Interest in Evofem Biosciences, Inc. (NASDAQ:EVFM) Rises By 627.8%

Evofem Biosciences, Inc. (NASDAQ:EVFM) was the target of a large increase in short interest in September. As of September 15th, there was short interest totaling 123,000 shares, an increase of 627.8% from the August 31st total of 16,900 shares. Based on an average trading volume of 1,404,200 shares, the short-interest ratio is presently 0.1 days. Based on an average trading volume of 1,404,200 shares, the short-interest ratio is presently 0.1 days.

Evofem Biosciences Price Performance

Shares of NASDAQ EVFM opened at $0.01 on Friday. Evofem Biosciences has a 1-year low of $0.01 and a 1-year high of $0.02. The business’s fifty day moving average price is $0.01 and its two-hundred day moving average price is $0.01. The firm has a market capitalization of $1.67 million, a PE ratio of -0.02 and a beta of -1.14.

About Evofem Biosciences

Evofem Biosciences, Inc, a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100 for the prevention of chlamydia and gonorrhea in Women, and EVO200 for the prevention of recurrent bacterial vaginosis.